Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0007-2015Class II

VITROS Chemistry Products PHYT (Phenytoin) Slides, REF/Product Code 829 8671, IVD. For in vitro diagnostic...

Ortho-Clinical Diagnostics, Inc. / initiated 2014-08-20 / Terminated / root cause: software

Ortho-Clinical Diagnostics began a recall of VITROS Chemistry Products PHYT (Phenytoin) Slides, REF/Product Code 829 8671, IVD. For in vitro diagnostic use only. VITROS Chemistry Products PHYT Slides... on . FDA classified it as Class II and gives the reason as "Ortho Clinical Diagnostics identified a potential for biased results to be generated when using VITROS PHYT Slides, Lot 2613-0150-4913. Some positively biased results were identified during testing of a different VITROS...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0007-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ortho-Clinical Diagnostics, Inc.
Product
VITROS Chemistry Products PHYT (Phenytoin) Slides, REF/Product Code 829 8671, IVD. For in vitro diagnostic use only. VITROS Chemistry Products PHYT Slides quantitatively measure phenytoin (PHYT) concentration in serum and plasma using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System.
Product code
DIP Enzyme Immunoassay, Diphenylhydantoin
Reason for recall
Ortho Clinical Diagnostics identified a potential for biased results to be generated when using VITROS PHYT Slides, Lot 2613-0150-4913. Some positively biased results were identified during testing of a different VITROS PHYT Slide lot; the affected slides were not released for distribution. Since Lot 2613-0150-4913 was manufactured in the same event, there is the potential for slides from this lot to also be affected.
Root cause tag
software
FDA root cause
Software Manufacturing/Software Deployment
Action
On 8/20/14, an URGENT PRODUCT CORRECTION NOTIFICATION Letter (CL2014-222, dated 8/20/14) was sent via FedEx overnight courier and/or ORTHO PLUS e-Communications and/or US Postal Service Priority Mail (for PO Boxes only) to US consignees (OCD Direct, Drop-Ship and US Federal Government) to inform them of the issue and advise them to discontinue use of the affected lot(s) and to inform their Laboratory Medical Director if they suspect that a previously reported result may have been affected. One foreign affiliate was notified on 8/20/14. One distributor was notified on 8/20/14. The customers were advised to: - Immediately discontinue using and discard VITROS Chemistry Products PHYT slide Lot 2613-0150-4913. Review VITROS PHYT results obtained using Lot 2613-0150-4913 and discuss any concerns they may have regarding previously reported results with their Laboratory Medical Director or with the requesting physician. Complete the attached Confirmation of Receipt form no later than 8/28/14. Forward the information in this notification if they have distributed this product outside of their facility facility.
Quantity in commerce
Domestic: 339 sales units; Foreign: 10 sales units
Distribution
Distributed USA (nationwide) and in Singapore.
Product codes and lots
Lot Number 2613-0150-4913, exp. 15-Nov-2014

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0007-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0007-2015Class IITerminatedVoluntary: Firm initiated